An interpretation of 2017 WHO guidelines on hepatitis B and C testing
-
摘要:
<正>2010和2014年世界卫生大会决议将病毒性肝炎认定为全球健康问题。同时世界卫生组织(WHO)制订并实施了针对病毒性肝炎的诊疗策略,旨在HBV和HCV诊断与治疗上为各成员国提供明确指导。但之前WHO没有制订关于HBV和HCV感染、检测人群及检测方式的指南。此次WHO乙型和丙型肝炎检
-
[1]WHO Guidelines Approved by the Guidelines Review Committee.Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection[EB/OL]. (2015-05) [2017-05].http://www.who.int/hiv/pub/hepatitis/hepatitis-B-quidelines/en/. [2]WHO Guidelines Approved by the Guidelines Review Committee.Guidelines for the screening care and treatment of persons with chronic hepatitis C infection:updated version[EB/OL]. (2016-04) [2017-05].http://apps.who.int/iris/bitstream/10665/205035/1/9789241549615_eng.pdf?ua=1, accessed 6 February2017. [3]BENHAMOU Y, BOCHET M, DI MARTINO V, et al.Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients.The Multivirc Group[J].Hepatology, 1999, 30 (4) :1054-1058. [4]THIO CL, GUO N, XIE C, et al.Global elimination of mother-to-child transmission of hepatitis B:revisiting the current strategy[J].Lancet Infect Dis, 2015, 15 (8) :981-985. [5]PATTON H, TRAN TT.Management of hepatitis B during pregnancy[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (7) :402-409.
本文二维码
计量
- 文章访问数: 2422
- HTML全文浏览量: 18
- PDF下载量: 530
- 被引次数: 0